Analysis of Human Neuronal Cells Carrying ASTN2 Deletion Associated with Psychiatric Disorders

Overview

Journal Transl Psychiatry

Specialties Psychiatry
Public Health

Date 2024 Jun 3

PMID 38830862

Authors

Yu Hayashi

Hiroki Okumura

Yuko Arioka

Itaru Kushima

Daisuke Mori

Tzuyao Lo

Gantsooj Otgonbayar

Hidekazu Kato

Yoshihiro Nawa

Hiroki Kimura

Branko Aleksic

Norio Ozaki

Affiliations

Soon will be listed here.

Abstract

Recent genetic studies have found common genomic risk variants among psychiatric disorders, strongly suggesting the overlaps in their molecular and cellular mechanism. Our research group identified the variant in ASTN2 as one of the candidate risk factors across these psychiatric disorders by whole-genome copy number variation analysis. However, the alterations in the human neuronal cells resulting from ASTN2 variants identified in patients remain unknown. To address this, we used patient-derived and genome-edited iPS cells with ASTN2 deletion; cells were further differentiated into neuronal cells. A comprehensive gene expression analysis using genome-edited iPS cells with variants on both alleles revealed that the expression level of ZNF558, a gene specifically expressed in human forebrain neural progenitor cells, was greatly reduced in ASTN2-deleted neuronal cells. Furthermore, the expression of the mitophagy-related gene SPATA18, which is repressed by ZNF558, and mitophagy activity were increased in ASTN2-deleted neuronal cells. These phenotypes were also detected in neuronal cells differentiated from patient-derived iPS cells with heterozygous ASTN2 deletion. Our results suggest that ASTN2 deletion is related to the common pathogenic mechanism of psychiatric disorders by regulating mitophagy via ZNF558.

References

Bond A, Ming G, Song H . Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later. Cell Stem Cell. 2015; 17(4):385-95. PMC: 4683085. DOI: 10.1016/j.stem.2015.09.003. View

Chahrour M, Yu T, Lim E, Ataman B, Coulter M, Hill R . Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 2012; 8(4):e1002635. PMC: 3325173. DOI: 10.1371/journal.pgen.1002635. View

Silbereis J, Pochareddy S, Zhu Y, Li M, Sestan N . The Cellular and Molecular Landscapes of the Developing Human Central Nervous System. Neuron. 2016; 89(2):248-68. PMC: 4959909. DOI: 10.1016/j.neuron.2015.12.008. View

Schwarz K, Moessnang C, Schweiger J, Baumeister S, Plichta M, Brandeis D . Transdiagnostic Prediction of Affective, Cognitive, and Social Function Through Brain Reward Anticipation in Schizophrenia, Bipolar Disorder, Major Depression, and Autism Spectrum Diagnoses. Schizophr Bull. 2019; 46(3):592-602. PMC: 7147576. DOI: 10.1093/schbul/sbz075. View

Mitani T, Isikay S, Gezdirici A, Gulec E, Punetha J, Fatih J . High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population. Am J Hum Genet. 2021; 108(10):1981-2005. PMC: 8546040. DOI: 10.1016/j.ajhg.2021.08.009. View

Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M . Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev. 2014; 48:10-21. DOI: 10.1016/j.neubiorev.2014.11.005. View

Ito T, Yoshida M, Aida T, Kushima I, Hiramatsu Y, Ono M . Astrotactin 2 (ASTN2) regulates emotional and cognitive functions by affecting neuronal morphogenesis and monoaminergic systems. J Neurochem. 2023; 165(2):211-229. DOI: 10.1111/jnc.15790. View

Mattson M, Gleichmann M, Cheng A . Mitochondria in neuroplasticity and neurological disorders. Neuron. 2008; 60(5):748-66. PMC: 2692277. DOI: 10.1016/j.neuron.2008.10.010. View

Rooney J, Ryde I, Sanders L, Howlett E, Colton M, Germ K . PCR based determination of mitochondrial DNA copy number in multiple species. Methods Mol Biol. 2014; 1241:23-38. PMC: 4312664. DOI: 10.1007/978-1-4939-1875-1_3. View

10.

Behesti H, Fore T, Wu P, Horn Z, Leppert M, Hull C . ASTN2 modulates synaptic strength by trafficking and degradation of surface proteins. Proc Natl Acad Sci U S A. 2018; 115(41):E9717-E9726. PMC: 6187130. DOI: 10.1073/pnas.1809382115. View

11.

Hodge R, Bakken T, Miller J, Smith K, Barkan E, Graybuck L . Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019; 573(7772):61-68. PMC: 6919571. DOI: 10.1038/s41586-019-1506-7. View

12.

Mattson M, PARTIN J . Evidence for mitochondrial control of neuronal polarity. J Neurosci Res. 1999; 56(1):8-20. DOI: 10.1002/(SICI)1097-4547(19990401)56:1<8::AID-JNR2>3.0.CO;2-G. View

13.

Shivakumar V, Rajasekaran A, Subbanna M, Kalmady S, Venugopal D, Agrawal R . Leukocyte mitochondrial DNA copy number in schizophrenia. Asian J Psychiatr. 2020; 53:102193. DOI: 10.1016/j.ajp.2020.102193. View

14.

Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y . Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Transl Psychiatry. 2016; 6(11):e934. PMC: 5314118. DOI: 10.1038/tp.2016.206. View

15.

Kato T, Baba K, Guo W, Chen Y, Nosaka T . Impact of bipolar disorder on health-related quality of life and work productivity: Estimates from the national health and wellness survey in Japan. J Affect Disord. 2021; 295:203-214. DOI: 10.1016/j.jad.2021.07.104. View

16.

Folsom T, Fatemi S . The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology. 2012; 68:122-35. PMC: 3632377. DOI: 10.1016/j.neuropharm.2012.08.015. View

17.

Sekiguchi M, Sobue A, Kushima I, Wang C, Arioka Y, Kato H . ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk. Transl Psychiatry. 2020; 10(1):247. PMC: 7376022. DOI: 10.1038/s41398-020-00917-z. View

18.

Mussazhanova Z, Shimamura M, Kurashige T, Ito M, Nakashima M, Nagayama Y . Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Cancer Sci. 2020; 111(8):2814-2823. PMC: 7419045. DOI: 10.1111/cas.14501. View

19.

Takata A, Miyake N, Tsurusaki Y, Fukai R, Miyatake S, Koshimizu E . Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. Cell Rep. 2018; 22(3):734-747. DOI: 10.1016/j.celrep.2017.12.074. View

20.

Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine J . Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004; 291(21):2581-90. DOI: 10.1001/jama.291.21.2581. View